Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pancreatitis

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    June 2022
  1. TAN PS, Garriga C, Clift A, Liao W, et al
    Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.
    Gut. 2022 Jun 27. pii: gutjnl-2021-326522. doi: 10.1136/gutjnl-2021-326522.
    PubMed     Abstract available


  2. BOXHOORN L, Verdonk RC, Besselink MG, Boermeester M, et al
    Comparison of lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis.
    Gut. 2022 Jun 14. pii: gutjnl-2021-325632. doi: 10.1136/gutjnl-2021-325632.
    PubMed     Abstract available


  3. WANG L, Liu Y, Dai Y, Tang X, et al
    Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.
    Gut. 2022 Jun 10. pii: gutjnl-2021-326070. doi: 10.1136/gutjnl-2021-326070.
    PubMed     Abstract available


    May 2022
  4. DE SANTIS MC, Gozzelino L, Margaria JP, Costamagna A, et al
    Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer.
    Gut. 2022 May 27. pii: gutjnl-2021-325117. doi: 10.1136/gutjnl-2021-325117.
    PubMed     Abstract available


  5. JANCSO Z, Demcsak A, Sahin-Toth M
    Modelling chronic pancreatitis as a complex genetic disease in mice.
    Gut. 2022 May 16. pii: gutjnl-2022-327601. doi: 10.1136/gutjnl-2022-327601.
    PubMed    


  6. ALFARANO G, Audano M, Di Chiaro P, Balestrieri C, et al
    Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells.
    Gut. 2022 May 13. pii: gutjnl-2021-325811. doi: 10.1136/gutjnl-2021-325811.
    PubMed     Abstract available


    April 2022
  7. YANG X, Yao L, Dai L, Yuan M, et al
    Alcohol predisposes obese mice to acute pancreatitis via adipose triglyceride lipase-dependent visceral adipocyte lipolysis.
    Gut. 2022 Apr 22. pii: gutjnl-2022-326958. doi: 10.1136/gutjnl-2022-326958.
    PubMed    


  8. ALONSO-NOCELO M, Ruiz-Canas L, Sancho P, Gorgulu K, et al
    Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma.
    Gut. 2022 Apr 15. pii: gutjnl-2021-325564. doi: 10.1136/gutjnl-2021-325564.
    PubMed     Abstract available


  9. COFFELT SB, Morton JP
    LOXL2 in pancreatic tumourigenesis: the complexity of tumour-stromal crosstalk exemplified.
    Gut. 2022 Apr 15. pii: gutjnl-2022-327430. doi: 10.1136/gutjnl-2022-327430.
    PubMed    



  10. Correction: Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Gut. 2022;71:e5.
    PubMed    


    March 2022
  11. KARTAL E, Schmidt TSB, Molina-Montes E, Rodriguez-Perales S, et al
    A faecal microbiota signature with high specificity for pancreatic cancer.
    Gut. 2022 Mar 8. pii: gutjnl-2021-324755. doi: 10.1136/gutjnl-2021-324755.
    PubMed     Abstract available


  12. NEWSOME R, Jobin C
    Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome.
    Gut. 2022 Mar 8. pii: gutjnl-2021-326710. doi: 10.1136/gutjnl-2021-326710.
    PubMed    


  13. HE Z, Zhao S, Wang S, Song S, et al
    Rare cause of recurrent acute pancreatitis: a double whammy from the pancreas and duodenum.
    Gut. 2022 Mar 4. pii: gutjnl-2021-326704. doi: 10.1136/gutjnl-2021-326704.
    PubMed    


    February 2022
  14. NAYAR M, Leeds JS, Oppong K
    Lumen-apposing metal stents for drainage of pancreatic fluid collections: does timing of removal matter?
    Gut. 2022 Feb 25. pii: gutjnl-2021-325812. doi: 10.1136/gutjnl-2021-325812.
    PubMed    


  15. AMATO A, Tarantino I, Facciorusso A, Binda C, et al
    Real-life multicentre study of lumen-apposing metal stent for EUS-guided drainage of pancreatic fluid collections.
    Gut. 2022 Feb 22. pii: gutjnl-2022-326880. doi: 10.1136/gutjnl-2022-326880.
    PubMed    


    January 2022
  16. KUMAR S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, et al
    Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model.
    Gut. 2022 Jan 24. pii: gutjnl-2021-324834. doi: 10.1136/gutjnl-2021-324834.
    PubMed     Abstract available


  17. VARGHESE C, Nayar M, Pandanaboyana S
    SARS-CoV-2 pandemic has impacted on patterns of aetiology for acute pancreatitis and management of gallstone pancreatitis in the UK.
    Gut. 2022 Jan 17. pii: gutjnl-2021-326845. doi: 10.1136/gutjnl-2021-326845.
    PubMed    


  18. BELLOMO G, Rainer C, Quaranta V, Astuti Y, et al
    Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis.
    Gut. 2022 Jan 12. pii: gutjnl-2021-325272. doi: 10.1136/gutjnl-2021-325272.
    PubMed     Abstract available


  19. RUIVO CF, Bastos N, Adem B, Batista I, et al
    Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression.
    Gut. 2022 Jan 10. pii: gutjnl-2021-324994. doi: 10.1136/gutjnl-2021-324994.
    PubMed     Abstract available


  20. WANG YC, Mao XT, Yu D, Mao SH, et al
    Alcohol amplifies the association between common variants at PRSS1-PRSS2 locus and chronic pancreatitis in a dose-dependent manner.
    Gut. 2022 Jan 7. pii: gutjnl-2021-326670. doi: 10.1136/gutjnl-2021-326670.
    PubMed    


    December 2021
  21. HUANG HC, Sung YC, Li CP, Wan D, et al
    Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours.
    Gut. 2021 Dec 17. pii: gutjnl-2021-325180. doi: 10.1136/gutjnl-2021-325180.
    PubMed     Abstract available


  22. ROSENDAHL J
    Understanding pain in chronic pancreatitis: not yet the end of the story?
    Gut. 2021 Dec 9. pii: gutjnl-2021-326279. doi: 10.1136/gutjnl-2021-326279.
    PubMed    


    November 2021
  23. NAYAR M, Varghese C, Kanwar A, Siriwardena AK, et al
    SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study.
    Gut. 2021 Nov 11. pii: gutjnl-2021-326218. doi: 10.1136/gutjnl-2021-326218.
    PubMed    


  24. BENITZ S, Crawford H
    Discovery of the pancreatic basal cell: a new candidate for an adult stem cell emerges.
    Gut. 2021 Nov 3. pii: gutjnl-2021-325694. doi: 10.1136/gutjnl-2021-325694.
    PubMed    


  25. EROSS B, Szentesi A, Hegyi P
    Metabolic signature might be an option to identify patients with early CP.
    Gut. 2021;70:2023-2024.
    PubMed    


    October 2021
  26. LEE B, Namkoong H, Yang Y, Huang H, et al
    Single-cell sequencing unveils distinct immune microenvironments with CCR6-CCL20 crosstalk in human chronic pancreatitis.
    Gut. 2021 Oct 26. pii: gutjnl-2021-324546. doi: 10.1136/gutjnl-2021-324546.
    PubMed     Abstract available


  27. CABASAG CJ, Ferlay J, Laversanne M, Vignat J, et al
    Pancreatic cancer: an increasing global public health concern.
    Gut. 2021 Oct 22. pii: gutjnl-2021-326311. doi: 10.1136/gutjnl-2021-326311.
    PubMed    


  28. OLESEN SS, Phillips AE, Faghih M, Kuhlmann L, et al
    Overlap and cumulative effects of pancreatic duct obstruction, abnormal pain processing and psychological distress on patient-reported outcomes in chronic pancreatitis.
    Gut. 2021 Oct 21. pii: gutjnl-2021-325855. doi: 10.1136/gutjnl-2021-325855.
    PubMed     Abstract available


  29. YANG F, Huang Y, Li T, Fu Y, et al
    Prevalence and outcomes of acute pancreatitis in COVID-19: a meta-analysis.
    Gut. 2021 Oct 20. pii: gutjnl-2021-325941. doi: 10.1136/gutjnl-2021-325941.
    PubMed    


  30. KRYKLYVA V, Luchini C, Stommel MWJ, Nagtegaal ID, et al
    Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry.
    Gut. 2021 Oct 19. pii: gutjnl-2021-326033. doi: 10.1136/gutjnl-2021-326033.
    PubMed    


    July 2021
  31. MARTENS S, Coolens K, Van Bulck M, Arsenijevic T, et al
    Discovery and 3D imaging of a novel DeltaNp63-expressing basal cell type in human pancreatic ducts with implications in disease.
    Gut. 2021 Jul 30. pii: gutjnl-2020-322874. doi: 10.1136/gutjnl-2020-322874.
    PubMed     Abstract available


  32. HALLENSLEBEN ND, Timmerhuis HC, Hollemans RA, Pocornie S, et al
    Optimal timing of cholecystectomy after necrotising biliary pancreatitis.
    Gut. 2021 Jul 16. pii: gutjnl-2021-324239. doi: 10.1136/gutjnl-2021-324239.
    PubMed     Abstract available


    June 2021
  33. POTJER TP
    Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria?
    Gut. 2021 Jun 18. pii: gutjnl-2021-324739. doi: 10.1136/gutjnl-2021-324739.
    PubMed    


  34. LV XH, Deng K, Yang JL
    Duality of the association between COVID-19 and acute pancreatitis.
    Gut. 2021 Jun 15. pii: gutjnl-2021-325221. doi: 10.1136/gutjnl-2021-325221.
    PubMed    


    May 2021
  35. KOSCHNY R, Lang M, Hackert T
    Enormously dilated pancreatic duct.
    Gut. 2021 May 7. pii: gutjnl-2021-324335. doi: 10.1136/gutjnl-2021-324335.
    PubMed    


  36. GENIN E, Cooper DN, Masson E, Ferec C, et al
    NGS mismapping confounds the clinical interpretation of the PRSS1 p.Ala16Val (c.47C>T) variant in chronic pancreatitis.
    Gut. 2021 May 7. pii: gutjnl-2021-324943. doi: 10.1136/gutjnl-2021-324943.
    PubMed    


    April 2021
  37. CHANDRA V, McAllister F
    Therapeutic potential of microbial modulation in pancreatic cancer.
    Gut. 2021 Apr 27. pii: gutjnl-2019-319807. doi: 10.1136/gutjnl-2019-319807.
    PubMed    


  38. HACKENG WM, Brosens LAA, Kim JY, O'Sullivan R, et al
    Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
    Gut. 2021 Apr 13. pii: gutjnl-2020-322595. doi: 10.1136/gutjnl-2020-322595.
    PubMed     Abstract available


  39. KLOESCH B, Ionasz V, Paliwal S, Hruschka N, et al
    A GATA6-centred gene regulatory network involving HNFs and DeltaNp63 controls plasticity and immune escape in pancreatic cancer.
    Gut. 2021 Apr 12. pii: gutjnl-2020-321397. doi: 10.1136/gutjnl-2020-321397.
    PubMed     Abstract available


  40. XIE Z, Gao Y, Ho C, Li L, et al
    Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
    Gut. 2021 Apr 7. pii: gutjnl-2020-323014. doi: 10.1136/gutjnl-2020-323014.
    PubMed     Abstract available


  41. OVERBEEK KA, Levink IJM, Koopmann BDM, Harinck F, et al
    Long-term yield of pancreatic cancer surveillance in high-risk individuals.
    Gut. 2021 Apr 5. pii: gutjnl-2020-323611. doi: 10.1136/gutjnl-2020-323611.
    PubMed     Abstract available


    March 2021
  42. GLEESON FC, Jeraldo P, Levy MJ, Murphy SJ, et al
    Composition, diversity and potential utility of intervention-naive pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound.
    Gut. 2021 Mar 22. pii: gutjnl-2021-324031. doi: 10.1136/gutjnl-2021-324031.
    PubMed    


  43. ZHOU T, Liu J, Xie Y, Yuan S, et al
    ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.
    Gut. 2021 Mar 5. pii: gutjnl-2020-321952. doi: 10.1136/gutjnl-2020-321952.
    PubMed     Abstract available


  44. KOLODKIN-GAL D, Roitman L, Ovadya Y, Azazmeh N, et al
    Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
    Gut. 2021 Mar 1. pii: gutjnl-2020-321112. doi: 10.1136/gutjnl-2020-321112.
    PubMed     Abstract available


    February 2021
  45. TACELLI M, Zaccari P, Capurso G, Arcidiacono PG, et al
    Artificial intelligence in EUS for autoimmune pancreatitis: bias and real life.
    Gut. 2021 Feb 22. pii: gutjnl-2021-324338. doi: 10.1136/gutjnl-2021-324338.
    PubMed    


  46. SUN X, He X, Zhang Y, Hosaka K, et al
    Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism.
    Gut. 2021 Feb 10. pii: gutjnl-2020-322744. doi: 10.1136/gutjnl-2020-322744.
    PubMed     Abstract available


  47. PANDANABOYANA S, Moir J, Leeds JS, Oppong K, et al
    SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.
    Gut. 2021 Feb 5. pii: gutjnl-2020-323364. doi: 10.1136/gutjnl-2020-323364.
    PubMed     Abstract available


  48. ADAM MG, Beyer G, Christiansen N, Kamlage B, et al
    Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects.
    Gut. 2021 Feb 4. pii: gutjnl-2020-320723. doi: 10.1136/gutjnl-2020-320723.
    PubMed     Abstract available


    January 2021
  49. LUCHINI C, Grant RC, Scarpa A, Gallinger S, et al
    Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
    Gut. 2021 Jan 19. pii: gutjnl-2020-323805. doi: 10.1136/gutjnl-2020-323805.
    PubMed    


    November 2020
  50. RANA SS, Gupta R
    Walled of necrosis, disconnected pancreatic duct and metal stents: the debate continues!
    Gut. 2020 Nov 9. pii: gutjnl-2020-323190. doi: 10.1136/gutjnl-2020-323190.
    PubMed    


  51. FROST F, Kacprowski T, Ruhlemann M, Pietzner M, et al
    Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function.
    Gut. 2020 Nov 9. pii: gutjnl-2020-322753. doi: 10.1136/gutjnl-2020-322753.
    PubMed     Abstract available


  52. KEMPENEERS MA, Issa Y, Verdonk RC, Bruno M, et al
    Pain patterns in chronic pancreatitis: a nationwide longitudinal cohort study.
    Gut. 2020 Nov 6. pii: gutjnl-2020-322117. doi: 10.1136/gutjnl-2020-322117.
    PubMed     Abstract available


    October 2020
  53. SANO M, Takahashi R, Ijichi H, Ishigaki K, et al
    Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
    Gut. 2020 Oct 21. pii: gutjnl-2020-320608. doi: 10.1136/gutjnl-2020-320608.
    PubMed     Abstract available


  54. MARYA NB, Powers PD, Chari ST, Gleeson FC, et al
    Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Gut. 2020 Oct 7. pii: gutjnl-2020-322821. doi: 10.1136/gutjnl-2020-322821.
    PubMed     Abstract available



  55. Correction: Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Gut. 2020;69:e6.
    PubMed    


  56. DIAFERIA GR, Natoli G
    Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A.
    Gut. 2020 Oct 1. pii: gutjnl-2020-322814. doi: 10.1136/gutjnl-2020-322814.
    PubMed    


    September 2020
  57. WEISS FU, Laemmerhirt F, Lerch MM
    Next generation sequencing pitfalls in diagnosing trypsinogen (PRSS1) mutations in chronic pancreatitis.
    Gut. 2020 Sep 28. pii: gutjnl-2020-322864. doi: 10.1136/gutjnl-2020-322864.
    PubMed    


  58. BARRETO SG, Habtezion A, Gukovskaya A, Lugea A, et al
    Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.
    Gut. 2020 Sep 24. pii: gutjnl-2020-322163. doi: 10.1136/gutjnl-2020-322163.
    PubMed     Abstract available


  59. GRANT RC, Denroche R, Jang GH, Nowak KM, et al
    Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
    Gut. 2020 Sep 15. pii: gutjnl-2020-320730. doi: 10.1136/gutjnl-2020-320730.
    PubMed     Abstract available


  60. YOUNG K, Lawlor RT, Ragulan C, Patil Y, et al
    Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
    Gut. 2020 Sep 3. pii: gutjnl-2020-321016. doi: 10.1136/gutjnl-2020-321016.
    PubMed     Abstract available


  61. GOUT J, Perkhofer L, Morawe M, Arnold F, et al
    Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.
    Gut. 2020 Sep 1. pii: gutjnl-2019-319970. doi: 10.1136/gutjnl-2019-319970.
    PubMed     Abstract available


  62. VAN DEN BERG FF, van Dalen D, Hyoju SK, van Santvoort HC, et al
    Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate.
    Gut. 2020 Sep 1. pii: gutjnl-2019-320430. doi: 10.1136/gutjnl-2019-320430.
    PubMed     Abstract available


    August 2020
  63. PERKHOFER L, Gout J, Roger E, Kude de Almeida F, et al
    DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives.
    Gut. 2020 Aug 27. pii: gutjnl-2019-319984. doi: 10.1136/gutjnl-2019-319984.
    PubMed     Abstract available


  64. CAMOLOTTO SA, Belova VK, Torre-Healy L, Vahrenkamp JM, et al
    Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4alpha and SIX1/4.
    Gut. 2020 Aug 21. pii: gutjnl-2020-321316. doi: 10.1136/gutjnl-2020-321316.
    PubMed     Abstract available


  65. BASHA J, Lakhtakia S, Nabi Z, Pal P, et al
    Impact of disconnected pancreatic duct on recurrence of fluid collections and new-onset diabetes: do we finally have an answer?
    Gut. 2020 Aug 18. pii: gutjnl-2020-321773. doi: 10.1136/gutjnl-2020-321773.
    PubMed    


  66. MASI AC, Oppong YEA, Haugk B, Lamb CA, et al
    Endoscopic ultrasound (EUS)-guided fine needle biopsy (FNB) formalin fixed paraffin-embedded (FFPE) pancreatic tissue samples are a potential resource for microbiota analysis.
    Gut. 2020 Aug 18. pii: gutjnl-2020-322457. doi: 10.1136/gutjnl-2020-322457.
    PubMed    


  67. HUANG J, Chen P, Liu K, Liu J, et al
    CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
    Gut. 2020 Aug 14. pii: gutjnl-2019-320441. doi: 10.1136/gutjnl-2019-320441.
    PubMed     Abstract available



  68. Correction: STING signalling protects against chronic pancreatitis by modulating Th17 response.
    Gut. 2020;69:e5.
    PubMed    


    July 2020
  69. AGHDASSI A, Tran QT, Bulla T, Bulow R, et al
    Focal pancreatic lesions in autoimmune pancreatitis and weight loss.
    Gut. 2020 Jul 22. pii: gutjnl-2020-321987. doi: 10.1136/gutjnl-2020-321987.
    PubMed    


    June 2020
  70. LESINSKI GB
    Braking the cell's cycle and invigorating T-cell immunity against pancreatic cancer.
    Gut. 2020 Jun 22. pii: gutjnl-2020-321497. doi: 10.1136/gutjnl-2020-321497.
    PubMed    


  71. GUBATAN J, Levitte S, Patel A, Balabanis T, et al
    Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.
    Gut. 2020 Jun 3. pii: gutjnl-2020-321772. doi: 10.1136/gutjnl-2020-321772.
    PubMed    



  72. Correction: Management of patients with increased risk for familial pancreatic cancer: updated recommendations for the international cancer of the pancreas screening (CAPS) Consortium.
    Gut. 2020;69:e3.
    PubMed    


    May 2020
  73. KNUDSEN ES, Kumarasamy V, Chung S, Ruiz A, et al
    Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer.
    Gut. 2020 May 18. pii: gutjnl-2020-321000. doi: 10.1136/gutjnl-2020-321000.
    PubMed     Abstract available


  74. MOLINA-MONTES E, Coscia C, Gomez-Rubio P, Fernandez A, et al
    Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.
    Gut. 2020 May 14. pii: gutjnl-2019-319990. doi: 10.1136/gutjnl-2019-319990.
    PubMed     Abstract available


  75. TAKAHASHI R, Macchini M, Sunagawa M, Jiang Z, et al
    Interleukin-1beta-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression.
    Gut. 2020 May 10. pii: gutjnl-2019-319912. doi: 10.1136/gutjnl-2019-319912.
    PubMed     Abstract available


    April 2020
  76. LUCHINI C, Brosens LAA, Wood LD, Chatterjee D, et al
    Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications.
    Gut. 2020 Apr 29. pii: gutjnl-2020-320726. doi: 10.1136/gutjnl-2020-320726.
    PubMed     Abstract available


  77. TIAN J, Zhu Y, Rao M, Cai Y, et al
    N(6)-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression.
    Gut. 2020 Apr 20. pii: gutjnl-2019-320179. doi: 10.1136/gutjnl-2019-320179.
    PubMed     Abstract available


  78. DE-MADARIA E, Sanchez-Marin C, Carrillo I, Vege SS, et al
    Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study.
    Gut. 2020 Apr 3. pii: gutjnl-2020-320729. doi: 10.1136/gutjnl-2020-320729.
    PubMed     Abstract available


  79. HU Q, Wu J, Ren Y, Wu X, et al
    Degree of STING activation is associated with disease outcomes.
    Gut. 2020;69:792-794.
    PubMed    


    February 2020
  80. BANG JY, Hawes RH, Varadarajulu S
    Lumen-apposing metal stent placement for drainage of pancreatic fluid collections: predictors of adverse events.
    Gut. 2020 Feb 17. pii: gutjnl-2019-320539. doi: 10.1136/gutjnl-2019-320539.
    PubMed    


  81. STOLZENBERG-SOLOMON R, Derkach A, Moore S, Weinstein SJ, et al
    Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
    Gut. 2020 Feb 14. pii: gutjnl-2019-319811. doi: 10.1136/gutjnl-2019-319811.
    PubMed     Abstract available


    January 2020
  82. BIEDERSTADT A, Hassan Z, Schneeweis C, Schick M, et al
    SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
    Gut. 2020 Jan 30. pii: gutjnl-2018-317856. doi: 10.1136/gutjnl-2018-317856.
    PubMed     Abstract available


  83. WAN J, Haddock A, Edenfield B, Ji B, et al
    Transgenic expression of human PRSS2 exacerbates pancreatitis in mice.
    Gut. 2020 Jan 23. pii: gutjnl-2019-320399. doi: 10.1136/gutjnl-2019-320399.
    PubMed    


    December 2019
  84. FRAMPTON AE, Giovannetti E
    Diagnosing pancreatic ductal adenocarcinoma using plasma extracellular vesicle RNA profiles.
    Gut. 2019 Dec 4. pii: gutjnl-2019-319896. doi: 10.1136/gutjnl-2019-319896.
    PubMed    


    October 2019
  85. GOGGINS M, Overbeek KA, Brand R, Syngal S, et al
    Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
    Gut. 2019 Oct 31. pii: gutjnl-2019-319352. doi: 10.1136/gutjnl-2019-319352.
    PubMed     Abstract available


  86. LIANG C, Shi S, Qin Y, Meng Q, et al
    Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Gut. 2019 Oct 14. pii: gutjnl-2018-317163. doi: 10.1136/gutjnl-2018-317163.
    PubMed     Abstract available


  87. TOLOSA EJ, Fernandez-Zapico ME
    Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer.
    Gut. 2019 Oct 3. pii: gutjnl-2019-318962. doi: 10.1136/gutjnl-2019-318962.
    PubMed    


    September 2019
  88. YU S, Li Y, Liao Z, Wang Z, et al
    Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Gut. 2019 Sep 27. pii: gutjnl-2019-318860. doi: 10.1136/gutjnl-2019-318860.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: